There are no approved treatments for nonrelapsing secondary progressive multiple sclerosis. In a phase 3, double-blind, placebo-controlled, event-driven trial, we randomly assigned participants ...

Secondary progressive multiple sclerosis (SPMS) can affect your ability to walk. Mobility support devices can help with symptoms like feeling unsteady or tripping. Types of devices include a ...

"With no treatment options currently available for the broad population of patients with secondary progressive multiple sclerosis, tolebrutinib has demonstrated its ability to delay disability by ...

The following is a summary of “Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study,” published in the May 2025 issue of European Journal of ...

There isn’t enough evidence to back the use of Novartis Mayzent for secondary progressive multiple sclerosis on the NHS (SPMS), despite a desperate lack of treatments for this form of the ...

Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting vs. progressive forms of MS, a ...

New research led by a St. Michael’s Hospital clinician-scientist and published in the prestigious New England Journal of ...

In this randomized controlled trial of patients with nonrelapsing secondary progressive multiple sclerosis (SPMS), oral ...